COVID-19 Research Collaboration
We acknowledge and thank those people on the frontline in our health system, as well as the clinical staff in research teams investigating the virus, the best treatments and vaccines. For the most up to date information about COVID-19, please visit the Queensland Health website.
Our mission is to enable the integration of innovative research with education, training, clinical care and the highest quality healthcare. During times of great hardship, Queenslanders band together, rolling up their sleeves to get done what needs to be done. That is what is happening now in health translational research to speed up Australia’s ability to find solutions to this pandemic.
BDHP’s collaborative network includes two leading Queensland universities, medical research institutes, private and public hospitals and the Queensland Department of Health. We have prioritised support for collaborations between clinical researchers, clinicians and innovators to progress COVID-19 health solutions and help to link them with our health system’s response.
We aim to:
- Support translational research coordination and collaboration, while the healthcare system focuses on responding to the virus
- Facilitate research translation for COVID-19 and ways to share data and patient samples
A simple app can save lives. As a member of the Australian Health Research Alliance, Brisbane Diamantina Health Partners is strongly supportive of the COVID-Safe app and encourage everyone to add it to their mobiles.
By Frank Gannon
BDHP strategic advisor Professor Frank Gannon is currently confined in Ireland, unable to return to work in Brisbane for the time being. He’s looked at the numbers worldwide to gauge how we’re going in the fight against COVID-19.
Stay up to date – BDHP COVID-19 Roundtable Discussion
COVID-19 Roundtable Discussions
BDHP is hosting a series of roundtable discussions to support the coordination of research efforts for COVID-19 and leverage the resources of our research and health services partners.
National and Queensland Information
Queensland Health statement on the impact of COVID-19 on older people for clinicians and researchers, see here
Guidance on clinical trials for institutions, HRECs, researchers and sponsors COVID-19: is a joint statement that reflects the shared views of all state and territory Departments of Health, the Therapeutic Goods Administration (TGA), NHMRC and the Clinical Trials Project Reference Group (CTPRG), of which all of these entities are members.
National Health and Medical Research Council (NHMRC) advice on addressing the challenges faced by clinical trial institutions, HRECs, researchers and sponsors during COVID19.
Clinical Trials Registers
These resources are up to date as at 6 May 2020.
BDHP Partner in COVID-19 news
Professor John Fraser, Prince Charles Hospital intensive care specialist leads a group collecting data on coronavirus patients in 26 hospitals globally to develop evidence-based recommendations on how best to treat patients with COVID-19.
A University of Queensland team has met a key milestone in their fast-tracked research to develop a vaccine for the coronavirus, COVID-19. In just three weeks, the team of researchers has created their first vaccine candidate in the laboratory and will move immediately into further development before formal pre-clinical testing.
Queensland researchers are set to begin clinical trials of a potential treatment for COVID-19 – using two existing drugs.
University of Queensland Centre for Clinical Research Director and Consultant Infectious Diseases Physician at the Royal Brisbane and Women’s Hospital (RBWH) and Leader of the BDHP Infection, Inflammation and Immunity Theme, Professor David Paterson said the drugs proved highly effective when first used against the virus in test tubes.
Respiratory researchers based at the Princess Alexandra Hospital and the Translational Research Institute are leading a clinical trial to test a potentially simple and inexpensive solution to older people succumbing to influenza.
Researchers at Griffith University in Brisbane have joined the race to create a vaccine for the coronavirus using a method that could see a vaccine rolled out in weeks once it’s approved. Scientists at the Griffith Institute for Drug Discovery (GRIDD) are about to start mouse model trials of four vaccine candidates they have developed.
Additional Curated Resources
Good Clinical Practice Training Course
The Western Australia Health Translation Network – RETProgram will provide members of the Australian Health Research Alliance, including Brisbane Diamantina Health Partners a discount to access our Good Clinical Practice (GCP) course. The modules are available here
Each participant will now pay $30 for access to this course. This discount is available until 1 June 2020. Access to the discounted GCP course can be gained by selecting “AHRA members” as the primary workplace when enrolling.
Please direct any queries, to RETProgram Support Team: firstname.lastname@example.org or 08 6151 0878
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use [link]